⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4931478 | 0.97 | SLC6A3 (0.35) | — | |
| SCHEMBL4294178 | 0.97 | SLC6A3 (0.35) | — | |
| Hydrochloric Acid SCHEMBL1622048 | 0.95 | SLC6A4 (0.34) | — | |
| SCHEMBL27128838 | 0.94 | — | — | |
| SCHEMBL9114190 | 0.79 | CHRM2 (0.34) | — | |
| SCHEMBL5605219 | 0.79 | OPRD1 (0.37) | — | |
| SCHEMBL28790729 | 0.79 | — | — | |
| SCHEMBL28205449 | 0.79 | SLC6A3 (0.37) | — | |
| SCHEMBL3707777 | 0.77 | ALDH1A1 (0.39) | — | |
| Hydrochloric Acid SCHEMBL5219661 | 0.75 | ALDH1A1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1828125-B1 | ARYLPIPERAZINE DERIVATIVES AND THEIR USE AS LIGANGS SELECTIVE OF THE DOPAMINE D3 RECEPTOR | BIOPROJET SOC CIV (FR) | 2008-04-09 | — | — | EP | disclosed |
| EP-1828125-A1 | ARYLPIPERAZINE DERIVATIVES AND THEIR USE AS LIGANGS SELECTIVE OF THE DOPAMINE D3 RECEPTOR | BIOPROJET (FR) | 2007-09-05 | — | — | EP | disclosed |
| US-7205311-B2 | Therapeutic acridone and acridine compounds | CANCER RESEARCH TECHNOLOGY LIMITED | 2007-04-17 | — | — | US | disclosed |
| WO-2006058993-A1 | ARYLPIPERAZINE DERIVATIVES AND THEIR USE AS LIGANDS SELECTIVE OF THE DOPAMINE D3 RECEPTOR | BIOPROJET (FR) | 2006-06-08 | — | — | WO | disclosed |
| US-20050070568-A1 | Therapeutic acridone and acridine compounds | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2005-03-31 | — | — | US | disclosed |
| EP-1474397-A1 | THERAPEUTIC ACRIDONE AND ACRIDINE COMPOUNDS | Cancer Research Technology Limited (GB) | 2004-11-10 | — | — | EP | disclosed |
| WO-2003059885-A1 | THERAPEUTIC ACRIDONE AND ACRIDINE COMPOUNDS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2003-07-24 | — | — | WO | disclosed |
| EP-0894800-B1 | Aliphatic solutions of aminoalkyllithium compounds | BRIDGESTONE CORP (JP) | 2003-03-12 | — | — | EP | disclosed |
| US-6046288-A | REDUCING ALIPHATIC SOLVENT AMOUNT NEEDED FOR MAINTAINING AMINOALKYLLITHIUM INITIATORS IN SOLUTION BY COMBINING A CYCLIC AMINOALKYLLITHIUM COMPOUND OF GIVEN FORMULA WITH A DISSIMILAR LITHIOAMINE USEFUL IN ANIONIC POLYMERIZATION | BRIDGESTONE CORPORATION (JP) | 2000-04-04 | — | — | US | disclosed |
| US-5935893-A | MIXTURE CONTAINING ANOTHER LITHIOAMINE COMPOUND; REDUCING AMOUNT OF SOLVENT NEEDED | BRIDGESTONE CORPORATION (JP) | 1999-08-10 | — | — | US | disclosed |
| EP-0894800-A2 | Aliphatic solutions of aminoalkyllithium compounds | Bridgestone Corporation (JP) | 1999-02-03 | — | — | EP | disclosed |
| US-4335122-A | DIURETICS | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1982-06-15 | — | — | US | disclosed |
| US-3993757-A | Method of treating inflammation with morphanthridines | RICHARDSON-MERRELL INC. (US) | 1976-11-23 | — | — | US | disclosed |